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RESEARCH NOTE
Association of anemia with sensorineural 
hearing loss: a systematic review 
and meta-analysis
Shimel Hussien Mohammed1* , Sakineh Shab‑Bidar2, Samer Abuzerr3, Tesfa Dejenie Habtewold4, 
Shahab Alizadeh5 and Kurosh Djafarian5
Abstract 
Objective: Evidence shows that anemic individuals are at a higher risk of hearing loss. However, there is no system‑
atic review and meta‑analysis study. Thus, we aimed to meta‑analyze the existing evidence on the association of iron 
deficiency anemia (IDA) with sensorineural hearing loss (SNHL). We searched PubMed, MEDLINE, Embase, Scopus, and 
Google Scholar from inception through October 30, 2017, for studies done on the association of the IDA with SNHL. 
Pooled odds ratio (OR) was calculated by random effect meta‑analysis method. Heterogeneity was assessed by  I2 
metrics.
Result: Four studies, covering a total of 344,080 adults and children, were included. The odds of SNHL was higher by 
55% in individuals with IDA, compared with individuals without IDA (OR = 1.55, 95% CI 1.17–2.06; P = 0.03). The age‑
specific ORs were 1.36 (95% CI 1.15–1.61; P = 0.27) and 3.67 (95% CI 1.72–7.84) for adults and children, respectively. 
IDA may be a contributing factor to hearing loss. Further studies are warranted, including whether IDA treatment 
reduces the risk of hearing loss. Meanwhile, hearing loss screening in anemic individuals, or vice versa, may represent 
an important consideration.
PROSPERO registration CRD42017082108
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Introduction
Anemia remains among the major global public health 
problems, affecting almost a third of the world popula-
tion (over 2.2 billion people) [1, 2]. Though it is a mul-
tifactorial problem, iron deficiency anemia (IDA) is 
estimated to account for almost half of the global anemia 
burden. There is a wide variation in the distribution of 
IDA, with the highest prevalence being in central Asia 
(64.7%) and lowest in North America (2.9%) [3–5]. Hear-
ing loss is also a significant public health challenge of a 
high, but less recognized, magnitude [6]. Although the 
figures may vary with the hearing assessment methods 
and thresholds used, hearing loss was estimated to affect 
360 [7] to 554 [8] million individuals globally. Hearing 
loss is an important contributor to childhood disability 
[9]. Hearing loss is of negative consequences, including 
poor psychosocial, cognitive and language developments 
in children [10] and cognitive decline, dementia, and 
social isolation in the elderly [11–14].
Existing evidence showed IDA linked to hearing loss. 
A higher prevalence of hearing loss was reported in indi-
viduals with IDA [15, 16]. The exact mechanism of IDA 
leading to hearing loss is mainly unclear. Whether IDA 
treatment improves hearing function is also unclear. 
However, it has been widely hypothesized to be related to 
the sensitivity of the cochlea to vascular and neurologic 
effects of IDA. Cochlea is supplied only by the labyrin-
thine artery. The lack of collateral circulation could make 
it more vulnerable to the ischemic effect of IDA [15–19]. 
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To the best of our knowledge, there is no systematic 
review and meta-analysis report on the association of 
anemia and hearing impairment. We, therefore, con-
ducted this systematic review and meta-analysis on the 
link of IDA to sensorineural hearing loss (SNHL).
Main text
Methods
This systematic review and meta-analysis was con-
ducted following the recommendations of Meta-analy-
sis of Observational Studies in Epidemiology guideline 
[20], and the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) [21]. The work 
was registered in PROSPERO.
Search strategy and data sources
We searched PubMed, MEDLINE, Embase, Scopus, and 
Google Scholar for studies published in English from 
inception to June 30, 2018. We used a combination of 
search terms including ‘anemia’, ‘anaemia’, ‘iron defi-
ciency anaemia’, ‘iron deficiency anemia’, ‘iron-deficiency 
anaemia’, ‘iron deficiency anemia’, ‘hearing loss’, ‘deafness’, 
‘hearing impairment’, and ‘hearing dysfunction’.
Eligibility criteria
The inclusion criteria were (1) hearing loss measured 
and reported, (2) IDA measured and reported, and (3) 
adjusted OR, incidence rate (IR), or relative risk (RR) 
reported on the association of anemia and hearing loss. 
The exclusion criteria were any one of the following con-
ditions: (1) animal studies; (2) celiac disease; (3) anemia 
of causes specified other than iron deficiency; or (4) 
qualitative studies, commentaries, editorials, and case 
reports.
Study screening and data extraction
Literature search, title, abstract and full-text screen-
ing and reviewing were done by SHM and SA, working 
independently and in duplicate. The screening and selec-
tion processes are illustrated using the PRISMA flow dia-
gram (Additional file  1). From each study, we extracted 
the following information: (1) study identification (title, 
first author, year of publication), (2) study characteristics 
(country, study design, sample size, follow-up period for 
longitudinal studies), (3) participants’ demographic fac-
tors (mean age, proportion of men), (4) IDA assessment 
method, (5) hearing loss assessment method, (6) measure 
of anemia and hearing loss association, and (7) variables 
used for adjustments. The pre-specified measures of 
association were adjusted OR, RR, or IR of hearing loss in 
individuals with IDA, compared with those without IDA. 
When a study reported more than one OR/RR, we took 
the maximum adjusted one that was adjusted for more 
variables. Besides, we treated RR as the equivalent of OR. 
For studies in which the reference of comparison was the 
risky group (individuals with IDA), we took the inverse 
of the reported estimate to ensure all estimates use the 
same reference group (individuals without IDA).
Quality assessment
We assessed the methodological quality of included stud-
ies using the Newcastle–Ottawa Scale (NOS) [22]. The 
grading was out of 9 and a score 0 to 3 was considered 
low quality, 4 to 6 medium quality, and 7–9 high quality. 
Ratings for each study were compared between the two 
evaluators, SHM and SA, with discrepancy resolved by 
consensus.
Statistical analysis
The OR was used to summarise the estimates, repre-
senting the odds of hearing loss in those with IDA, com-
pared with those without IDA. The summary OR was 
calculated with the DerSimonian and Laird random 
effect model, which accounts for both within study and 
between studies variations [23]. Heterogeneity between 
studies was assessed using the  I2-statistics, which quan-
tifies the proportion of variance explained by between-
study heterogeneity. According to Higgins et  al. [24], 
 I2 < 25%, 25–49%, 50–75%, and > 75% represents no, low, 
moderate and high levels of heterogeneity, respectively. 
Potential sources of heterogeneity were identified using 
subgroup analyses. We intended to assess publication 
bias using the funnel plot technique, Begg’s rank test, and 
Egger’s regression test, as appropriate. However, it was 
not possible as there were inadequate numbers of studies, 
which under-power any of these methods. A minimum of 
10 studies is recommended to evaluate publication bias, 
although a meta-analysis of 2 or more studies is possible 
[25]. Stata 15.0 was used for all analyses.
Result
We included a total of four studies [15–18] in this work. 
The literature search, selection and reviewing process is 
shown in the PRISMA flow diagram (Additional file  1). 
The general characteristic of the studies is presented in 
Table 1. The studies were published from 2011 to 2017. 
Of the four studies included in this work, three were 
cohort and one was case–control. Except one study done 
in Taiwan, the remaining three studies were conducted 
in the USA. The quality of the studies was high, all scor-
ing > 7/9 on the NOS quality assessment tool. The sample 
size of the studies ranged from 2612 to 305,339 individu-
als. Altogether, the four studies included 344,080 unique 
individuals, of whom 49.60% were males (n = 151,461) 
and 50.40% females (n = 153,878). The mean age of 
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participants was 48.2  years. Of the four studies, three 
were done on adults and one on children and adolescents.
Figure 1 shows the summary estimate of the association 
of IDA with hearing loss, calculated combining all the 
studies with random effect model. The estimates (ORs) 
refer to the odds of hearing impairment among anemic 
cases, as compared with non-anemic ones. It showed 
IDA significantly associated with hearing loss (pooled 
OR = 1.55, 95%CI 1.17-2.06) with a moderate level of 
heterogeneity (Q = 9.06, df = 3;  I2 = 66.9%, P = 0.03 for 
heterogeneity). Subgroup analysis was conducted by age 
groups, separating studies on adult and children. Fig-
ure  2 shows the results of the subgroup analyses. The 
child study seemed to explain the heterogeneity between 
the studies. Exclusion of this study resulted in a lower 
level of heterogeneity (Adult: Q = 2.63, df = 2;  I2 = 23.9%, 
P = 0.27), but the associations remained significant and 
almost the same (pooled OR = 1.55, 95 CI% = 1.17–2.06 
versus 1.36, 95% CI 1.15–1.61; with and without the child 
study included). Thus, the summary estimate of odds of 
SNHL associated with IDA was 1.36 (95% CI 1.15–1.61; 
 I2 = 23.9, P = 0.27) in adults and 3.67 (95% CI 1.72–7.84) 
in children and adolescents.
Discussion
We found a significant association between IDA and 
SNHL among both adults and children. The odds of 
SNHL was 55% higher in individuals with IDA, com-
pared with those without IDA. A recent study in the USA 
showed that the prevalence of hearing impairment was 
3.0% in children with IDA, but 1.7% in those without IDA 
[15]. In general, hearing impairment was estimated to 
affect 10% of the world population in the year 2015 [2], 
with significant variations across age groups as well as 
geographic regions. In 2011, 20.6% American adults aged 
48–59  years and 90% of those older than 80  years were 
reported to have hearing impairment [16], with an esti-
mated overall adult prevalence of 14.1% [17].
Table 1 Main characteristics of studies included in this meta-analysis
a Iron deficiency anemia; bCC = case–control; cSNHL = Sensorineural hearing loss




Schieffer 2017 [15] USA Children Cohort 20,113 9 Serum ferritin
Hemoglobin
SNHLc
Schieffer 2017 [17] USA Adults Cohort 305,339 9 Serum ferritin
Hemoglobin
SNHL
Chung 2014 [18] Taiwan Adults CCb 16,016 8 Serum ferritin
Hemoglobin
SNHL
Nash 2011 [16] USA Adults Cohort 2612 9 Hematocrit SNHL
Fig. 1 Association of iron deficiency anemia and sensorineural hearing loss
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The mechanism linking IDA and SNHL is uncertain 
and non-conclusive, through some plausible mechanisms 
were proposed. A more frequently mentioned mecha-
nism is the vascular hypothesis that the cochlea is sus-
ceptible to ischemia due to lack of collateral circulation. 
Provided iron is essential for the production of hemo-
globin, one could presume IDA will likely compromise 
tissue oxygen delivery [3, 4, 18] and increase the risk of 
ischemia [18, 26]. Cochlea receives blood from only the 
labyrinthine artery and would be more vulnerable to a 
reduction in blood oxygen due to IDA. Another proposed 
mechanism is the role of iron in the nervous system. Iron 
is a cofactor in neurotransmitter metabolism, DNA syn-
thesis, and nerve myelination [27, 28]. Neurological dis-
orders like epilepsy, peripheral  neuropathy, myoclonus, 
posterior column demyelination, headache, cerebellar 
ataxia, brain atrophy, and dementia might be linked to 
SNHL. Celiac disease has also been associated with hear-
ing impairment, due to reasons including impairment in 
nutritional status, diarrhea, abdominal distension and 
weight loss [29].
Anemia and hearing loss are among the top leading 
contributors to health impairment globally [2]. Anemia 
prevention and control is a global priority agenda [5]. 
Unlike anemia, hearing loss is in the rank of neglected 
problems, with low public health attention [6, 7]. Stud-
ies on IDA and hearing loss are limited in number as 
well as geographic coverage. The existing estimates are 
based mainly on studies conducted in western countries, 
where prevalence IDA is low and the possibility of early 
diagnosis and treatment is better, compared with the 
regions of Asia and Africa where both IDA and hearing 
loss burdens are high [8]. Thus, presuming IDA might be 
a risk factor for hearing loss, we believe that the number 
of people with hearing loss may be even higher than the 
reported figures in the literature. Further studies from 
developing countries would contribute to further under-
standing the nature and extent of the association of the 
two conditions.
While IDA remains a major public health problem 
globally, its association with hearing loss would be more 
concerning. The existing evidence is limited on whether 
anemia prevention and treatment reduces the risk of 
hearing loss or treatment of anemia in individuals with 
concurrent anemia and hearing impairment improves 
hearing function. Although the design of the studies 
included in our work precluded making a causal infer-
ence and definitive conclusion, we suggest further studies 
on the feasibility and effectiveness of hearing loss screen-
ing for individuals with anemia or anemia screening for 
individuals with hearing loss. Prevention, early diagnosis, 
and treatment of IDA could have dual benefits, reducing 
the burden of anemia and probably hearing loss. Previous 
reports also recommended the importance of screening 
[15, 17, 18]. Consideration of hearing loss screening for 
anemic individuals may stand more important in settings 
Fig. 2 Subgroup analysis of association iron deficiency anemia and sensorineural hearing loss
Page 5 of 6Mohammed et al. BMC Res Notes          (2019) 12:283 
with high anemia prevalence. Strategies for integrating 
hearing loss screening for anemic cases, or vice versa, 
into existing public health and clinical practices need to 
be explored by further studies. Anemia prevention and 
control is a centrality in national and global nutrition 
programs, with established delivery platforms. Thus, 
integrating hearing loss with anemia prevention and con-
trol delivery platforms may be an efficient option, albeit it 
should be confirmed in future studies.
Conclusion
This study showed a significant association between IDA 
and hearing loss. The exact mechanism by which IDA 
contributes to hearing loss, and whether IDA treatment 
reduces the risk of hearing loss is unclear. Further stud-
ies are warranted to better understand the link between 
IDA and hearing loss and draw public health attention. 
Besides, the potential of integrating hearing loss screen-
ing for anemic patients, or vice versa, needs to be further 
explored.
Limitations
• We found only four studies, which underpowered 
any of the existing publication bias evaluation meth-
ods.
• Except one study done from Taiwan, the other stud-
ies refer only to the US population, limiting the gen-
eralizability of the findings to the rest of the world.
• All studies were observational in design, precluding 
making causal inferences.
Additional file
Additional file 1. PRISMA flow diagram of study selection and screening.
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